Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.30013294 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.99761245 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.99761245 |
4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.50129842 |
5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.29224155 |
6 | negative regulation of cell killing (GO:0031342) | 5.29224155 |
7 | detection of bacterium (GO:0016045) | 4.90561872 |
8 | detection of other organism (GO:0098543) | 4.90282650 |
9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.79307503 |
10 | leukocyte aggregation (GO:0070486) | 4.77815180 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.70765709 |
12 | positive thymic T cell selection (GO:0045059) | 4.38941071 |
13 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.21468391 |
14 | NIK/NF-kappaB signaling (GO:0038061) | 4.20350347 |
15 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.18259011 |
16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.16770318 |
17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.16770318 |
18 | modulation by symbiont of host immune response (GO:0052553) | 4.16770318 |
19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.16770318 |
20 | modulation by symbiont of host defense response (GO:0052031) | 4.16770318 |
21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.16770318 |
22 | negative thymic T cell selection (GO:0045060) | 4.16349272 |
23 | negative T cell selection (GO:0043383) | 4.14001447 |
24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.11329509 |
25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.09199911 |
26 | response to muramyl dipeptide (GO:0032495) | 3.98662841 |
27 | positive regulation of B cell differentiation (GO:0045579) | 3.95746805 |
28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.94349040 |
29 | T cell migration (GO:0072678) | 3.89369997 |
30 | tolerance induction (GO:0002507) | 3.89020178 |
31 | negative regulation of T cell mediated immunity (GO:0002710) | 3.84918773 |
32 | detection of external biotic stimulus (GO:0098581) | 3.84552046 |
33 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.78841148 |
34 | negative regulation of interleukin-12 production (GO:0032695) | 3.77098616 |
35 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.73479776 |
36 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.70555325 |
37 | thymic T cell selection (GO:0045061) | 3.68983787 |
38 | regulation of B cell differentiation (GO:0045577) | 3.68013093 |
39 | cellular extravasation (GO:0045123) | 3.64938145 |
40 | positive T cell selection (GO:0043368) | 3.62515494 |
41 | response to interleukin-15 (GO:0070672) | 3.61039848 |
42 | response to peptidoglycan (GO:0032494) | 3.56680006 |
43 | interferon-gamma production (GO:0032609) | 3.50586062 |
44 | T cell selection (GO:0045058) | 3.46989966 |
45 | regulation of mast cell degranulation (GO:0043304) | 3.42947028 |
46 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.41768546 |
47 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.41196685 |
48 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.40112107 |
49 | detection of biotic stimulus (GO:0009595) | 3.39040135 |
50 | microglial cell activation (GO:0001774) | 3.35508383 |
51 | respiratory burst (GO:0045730) | 3.33753564 |
52 | regulation of T cell tolerance induction (GO:0002664) | 3.31882251 |
53 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.31330754 |
54 | B cell receptor signaling pathway (GO:0050853) | 3.30403107 |
55 | leukocyte cell-cell adhesion (GO:0007159) | 3.28603226 |
56 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.27345319 |
57 | myeloid dendritic cell activation (GO:0001773) | 3.26730403 |
58 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.24170877 |
59 | neutrophil activation involved in immune response (GO:0002283) | 3.22908871 |
60 | myeloid dendritic cell differentiation (GO:0043011) | 3.21160187 |
61 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.19912521 |
62 | regulation of tolerance induction (GO:0002643) | 3.19517177 |
63 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.18753913 |
64 | immunoglobulin mediated immune response (GO:0016064) | 3.17981688 |
65 | positive regulation of antigen processing and presentation (GO:0002579) | 3.17856254 |
66 | activated T cell proliferation (GO:0050798) | 3.16538988 |
67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.15094607 |
68 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.14768756 |
69 | leukocyte degranulation (GO:0043299) | 3.14670854 |
70 | positive regulation of mast cell activation (GO:0033005) | 3.08882513 |
71 | detection of molecule of bacterial origin (GO:0032490) | 3.07990205 |
72 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.06383986 |
73 | macrophage activation (GO:0042116) | 3.06254513 |
74 | regulation of mast cell activation (GO:0033003) | 3.06186872 |
75 | B cell mediated immunity (GO:0019724) | 3.05388711 |
76 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.05276353 |
77 | response to type I interferon (GO:0034340) | 3.05237913 |
78 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.05229263 |
79 | positive regulation of interleukin-2 production (GO:0032743) | 3.04908256 |
80 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.04861913 |
81 | negative regulation of innate immune response (GO:0045824) | 3.04720470 |
82 | regulation of leukocyte degranulation (GO:0043300) | 3.03811169 |
83 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.03587991 |
84 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.03587991 |
85 | positive regulation of granulocyte differentiation (GO:0030854) | 3.03200988 |
86 | T cell homeostasis (GO:0043029) | 3.02998796 |
87 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.02596604 |
88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.01161511 |
89 | macrophage activation involved in immune response (GO:0002281) | 3.00724743 |
90 | negative regulation of interleukin-6 production (GO:0032715) | 3.00590133 |
91 | cellular response to type I interferon (GO:0071357) | 2.99487852 |
92 | type I interferon signaling pathway (GO:0060337) | 2.99487852 |
93 | T cell receptor signaling pathway (GO:0050852) | 2.98203235 |
94 | positive regulation of isotype switching (GO:0045830) | 2.98177226 |
95 | positive regulation of humoral immune response (GO:0002922) | 2.97581146 |
96 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.97004199 |
97 | negative regulation of phagocytosis (GO:0050765) | 2.96886009 |
98 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96325003 |
99 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.95961569 |
100 | mature B cell differentiation (GO:0002335) | 2.93024538 |
101 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.92489203 |
102 | response to protozoan (GO:0001562) | 2.92336021 |
103 | neutrophil activation (GO:0042119) | 2.92027671 |
104 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.91996179 |
105 | lymphocyte homeostasis (GO:0002260) | 2.90573773 |
106 | cellular response to interleukin-15 (GO:0071350) | 2.89336208 |
107 | myeloid cell activation involved in immune response (GO:0002275) | 2.87705924 |
108 | positive regulation of interferon-alpha production (GO:0032727) | 2.84052254 |
109 | defense response to protozoan (GO:0042832) | 2.83643826 |
110 | T cell proliferation (GO:0042098) | 2.83417154 |
111 | regulation of response to interferon-gamma (GO:0060330) | 2.79946139 |
112 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.79825158 |
113 | response to host immune response (GO:0052572) | 2.79825158 |
114 | granulocyte activation (GO:0036230) | 2.79606686 |
115 | germinal center formation (GO:0002467) | 2.79509638 |
116 | mast cell activation (GO:0045576) | 2.78367745 |
117 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.78151067 |
118 | positive regulation of B cell mediated immunity (GO:0002714) | 2.78151067 |
119 | T cell costimulation (GO:0031295) | 2.77445707 |
120 | B cell homeostasis (GO:0001782) | 2.77393393 |
121 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.76453160 |
122 | natural killer cell differentiation (GO:0001779) | 2.75984681 |
123 | regulation of interferon-alpha production (GO:0032647) | 2.75371474 |
124 | response to fungus (GO:0009620) | 2.73978075 |
125 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.73132549 |
126 | response to host (GO:0075136) | 2.73132549 |
127 | response to host defenses (GO:0052200) | 2.73132549 |
128 | lymphocyte costimulation (GO:0031294) | 2.71888107 |
129 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.71829733 |
130 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.70741472 |
131 | modulation by symbiont of host cellular process (GO:0044068) | 2.70413817 |
132 | regulation of antigen processing and presentation (GO:0002577) | 2.68550164 |
133 | neutrophil mediated immunity (GO:0002446) | 2.67782699 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.32620858 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.27127160 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.23657801 |
4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.95478956 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.78803630 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.76599834 |
7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.50885505 |
8 | MYC_22102868_ChIP-Seq_BL_Human | 3.38261078 |
9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.29713059 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.20359945 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.10156257 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01345951 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.93915885 |
14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.91664915 |
15 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.91207812 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.85207901 |
17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.83810113 |
18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80346532 |
19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.66624889 |
20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.62740408 |
21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.60479436 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.57228915 |
23 | MAF_26560356_Chip-Seq_TH1_Human | 2.56379012 |
24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.51962118 |
25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.45860338 |
26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.35157298 |
27 | MYB_26560356_Chip-Seq_TH1_Human | 2.32609479 |
28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.32332462 |
29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.30602845 |
30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.28303363 |
31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27149608 |
32 | UTX_26944678_Chip-Seq_JUKART_Human | 2.26882384 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.16831179 |
34 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.10211873 |
35 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.07485484 |
36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03066949 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.89474038 |
38 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88642581 |
39 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.85094550 |
40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.84412447 |
41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80781445 |
42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80569342 |
43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.77723562 |
44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.72502105 |
45 | * MAF_26560356_Chip-Seq_TH2_Human | 1.70168032 |
46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66313763 |
47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60974875 |
48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59596352 |
49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.58040497 |
50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51861118 |
51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51507086 |
52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.48890847 |
53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48709420 |
54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.48324193 |
55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45861188 |
56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44544996 |
57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43623549 |
58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42488978 |
59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.42392958 |
60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32487173 |
61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30691915 |
62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29919960 |
63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28868039 |
64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28713039 |
65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.27995510 |
66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.24166818 |
67 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23684951 |
68 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.23518972 |
69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20733790 |
70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18480265 |
71 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17611461 |
72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13417804 |
73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12981471 |
74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11013097 |
75 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10153354 |
76 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09161368 |
77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08975409 |
78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05654222 |
79 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05190905 |
80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02271034 |
81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02178274 |
82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01158464 |
83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00722308 |
84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.00204599 |
85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00030622 |
86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99666943 |
87 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99122506 |
88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98374589 |
89 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.98353094 |
90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96428404 |
91 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96317093 |
92 | P68_20966046_ChIP-Seq_HELA_Human | 0.95514908 |
93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94592549 |
94 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94508870 |
95 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94118438 |
96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93214249 |
97 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.91877526 |
98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90997709 |
99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89720489 |
100 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87835374 |
101 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84215252 |
102 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81825540 |
103 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.80618110 |
104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80431842 |
105 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80107695 |
106 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.79962057 |
107 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.79231771 |
108 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.78548281 |
109 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76601699 |
110 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76448050 |
111 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73621185 |
112 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.73042853 |
113 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.72833172 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.74366342 |
2 | MP0003303_peritoneal_inflammation | 3.67043464 |
3 | MP0000685_abnormal_immune_system | 3.28115349 |
4 | MP0003436_decreased_susceptibility_to | 3.27888758 |
5 | MP0005671_abnormal_response_to | 3.05521548 |
6 | MP0001800_abnormal_humoral_immune | 3.00684377 |
7 | MP0005387_immune_system_phenotype | 2.97573927 |
8 | MP0001790_abnormal_immune_system | 2.97573927 |
9 | MP0003763_abnormal_thymus_physiology | 2.88062759 |
10 | MP0005000_abnormal_immune_tolerance | 2.83889787 |
11 | MP0009785_altered_susceptibility_to | 2.80729722 |
12 | MP0002452_abnormal_antigen_presenting | 2.69931063 |
13 | MP0002723_abnormal_immune_serum | 2.66007918 |
14 | MP0005025_abnormal_response_to | 2.61921792 |
15 | MP0002419_abnormal_innate_immunity | 2.61239087 |
16 | MP0002420_abnormal_adaptive_immunity | 2.56413506 |
17 | MP0001819_abnormal_immune_cell | 2.55579743 |
18 | MP0003300_gastrointestinal_ulcer | 2.52554099 |
19 | MP0004510_myositis | 2.38544138 |
20 | MP0002398_abnormal_bone_marrow | 2.37680265 |
21 | MP0006082_CNS_inflammation | 2.37629511 |
22 | MP0009278_abnormal_bone_marrow | 2.33803581 |
23 | MP0005464_abnormal_platelet_physiology | 2.32784122 |
24 | MP0002405_respiratory_system_inflammati | 2.31511011 |
25 | MP0002396_abnormal_hematopoietic_system | 2.30963889 |
26 | MP0002148_abnormal_hypersensitivity_rea | 2.18197956 |
27 | MP0000716_abnormal_immune_system | 2.14469277 |
28 | MP0001873_stomach_inflammation | 2.10563548 |
29 | MP0002166_altered_tumor_susceptibility | 2.10230140 |
30 | MP0004947_skin_inflammation | 2.06724328 |
31 | MP0009333_abnormal_splenocyte_physiolog | 2.01399503 |
32 | MP0010155_abnormal_intestine_physiology | 1.98329723 |
33 | MP0000689_abnormal_spleen_morphology | 1.97067222 |
34 | MP0004808_abnormal_hematopoietic_stem | 1.95586927 |
35 | MP0002722_abnormal_immune_system | 1.94910879 |
36 | MP0005397_hematopoietic_system_phenotyp | 1.91598595 |
37 | MP0001545_abnormal_hematopoietic_system | 1.91598595 |
38 | MP0001853_heart_inflammation | 1.81248241 |
39 | MP0003724_increased_susceptibility_to | 1.81102426 |
40 | MP0002429_abnormal_blood_cell | 1.80001480 |
41 | MP0001845_abnormal_inflammatory_respons | 1.79782394 |
42 | MP0002006_tumorigenesis | 1.78985724 |
43 | MP0000703_abnormal_thymus_morphology | 1.76981108 |
44 | MP0003172_abnormal_lysosome_physiology | 1.71025189 |
45 | MP0005058_abnormal_lysosome_morphology | 1.67987604 |
46 | MP0000465_gastrointestinal_hemorrhage | 1.60729941 |
47 | MP0001533_abnormal_skeleton_physiology | 1.59060674 |
48 | MP0003866_abnormal_defecation | 1.58587532 |
49 | MP0008260_abnormal_autophagy | 1.57238885 |
50 | MP0002132_abnormal_respiratory_system | 1.55985731 |
51 | MP0004381_abnormal_hair_follicle | 1.47167437 |
52 | MP0000569_abnormal_digit_pigmentation | 1.47065595 |
53 | MP0005174_abnormal_tail_pigmentation | 1.46970453 |
54 | MP0005310_abnormal_salivary_gland | 1.46676586 |
55 | MP0010307_abnormal_tumor_latency | 1.39395285 |
56 | MP0003183_abnormal_peptide_metabolism | 1.36860337 |
57 | MP0008469_abnormal_protein_level | 1.35994463 |
58 | MP0003448_altered_tumor_morphology | 1.34521660 |
59 | MP0002933_joint_inflammation | 1.31807940 |
60 | MP0005076_abnormal_cell_differentiation | 1.30172309 |
61 | MP0001986_abnormal_taste_sensitivity | 1.26915497 |
62 | MP0001851_eye_inflammation | 1.26605129 |
63 | MP0000490_abnormal_crypts_of | 1.24056701 |
64 | MP0010352_gastrointestinal_tract_polyps | 1.23915772 |
65 | MP0000858_altered_metastatic_potential | 1.22801041 |
66 | MP0005451_abnormal_body_composition | 1.19981686 |
67 | MP0009840_abnormal_foam_cell | 1.17669867 |
68 | MP0003191_abnormal_cellular_cholesterol | 1.17222145 |
69 | MP0002277_abnormal_respiratory_mucosa | 1.06870306 |
70 | MP0004883_abnormal_blood_vessel | 1.02071485 |
71 | MP0002998_abnormal_bone_remodeling | 0.96677643 |
72 | MP0000343_altered_response_to | 0.96004156 |
73 | MP0009764_decreased_sensitivity_to | 0.89420059 |
74 | MP0002009_preneoplasia | 0.88673602 |
75 | MP0002019_abnormal_tumor_incidence | 0.88265356 |
76 | MP0000015_abnormal_ear_pigmentation | 0.87070053 |
77 | MP0003566_abnormal_cell_adhesion | 0.86761868 |
78 | MP0000604_amyloidosis | 0.85237771 |
79 | MP0002138_abnormal_hepatobiliary_system | 0.84403290 |
80 | MP0003690_abnormal_glial_cell | 0.80296606 |
81 | MP0005023_abnormal_wound_healing | 0.77672724 |
82 | MP0003075_altered_response_to | 0.77477866 |
83 | MP0009763_increased_sensitivity_to | 0.76358263 |
84 | MP0003693_abnormal_embryo_hatching | 0.76007619 |
85 | MP0008961_abnormal_basal_metabolism | 0.75264673 |
86 | MP0008057_abnormal_DNA_replication | 0.73658337 |
87 | MP0001663_abnormal_digestive_system | 0.72137289 |
88 | MP0005075_abnormal_melanosome_morpholog | 0.71269444 |
89 | MP0003453_abnormal_keratinocyte_physiol | 0.70727504 |
90 | MP0000371_diluted_coat_color | 0.67393730 |
91 | MP0005166_decreased_susceptibility_to | 0.66510282 |
92 | MP0003077_abnormal_cell_cycle | 0.65812080 |
93 | MP0003828_pulmonary_edema | 0.63802362 |
94 | MP0005164_abnormal_response_to | 0.63549568 |
95 | MP0003091_abnormal_cell_migration | 0.61629591 |
96 | MP0002693_abnormal_pancreas_physiology | 0.61565310 |
97 | MP0005390_skeleton_phenotype | 0.61089119 |
98 | MP0008874_decreased_physiological_sensi | 0.59458685 |
99 | MP0003795_abnormal_bone_structure | 0.59320886 |
100 | MP0000313_abnormal_cell_death | 0.58730794 |
101 | MP0000249_abnormal_blood_vessel | 0.57939741 |
102 | MP0008004_abnormal_stomach_pH | 0.57926140 |
103 | MP0005381_digestive/alimentary_phenotyp | 0.57402423 |
104 | MP0000609_abnormal_liver_physiology | 0.55182652 |
105 | MP0008873_increased_physiological_sensi | 0.54242692 |
106 | MP0003045_fibrosis | 0.54171184 |
107 | MP0010094_abnormal_chromosome_stability | 0.52941020 |
108 | MP0003656_abnormal_erythrocyte_physiolo | 0.52053255 |
109 | MP0009765_abnormal_xenobiotic_induced | 0.50683532 |
110 | MP0002928_abnormal_bile_duct | 0.50485101 |
111 | MP0004130_abnormal_muscle_cell | 0.50296825 |
112 | MP0002877_abnormal_melanocyte_morpholog | 0.50064523 |
113 | MP0005621_abnormal_cell_physiology | 0.50009870 |
114 | MP0002136_abnormal_kidney_physiology | 0.49836316 |
115 | MP0002095_abnormal_skin_pigmentation | 0.48157620 |
116 | MP0005535_abnormal_body_temperature | 0.46804604 |
117 | MP0000470_abnormal_stomach_morphology | 0.44239368 |
118 | MP0001348_abnormal_lacrimal_gland | 0.41423270 |
119 | MP0002133_abnormal_respiratory_system | 0.40543050 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.02230823 |
2 | Recurrent abscess formation (HP:0002722) | 5.49626926 |
3 | Recurrent bacterial skin infections (HP:0005406) | 4.95949297 |
4 | Recurrent fungal infections (HP:0002841) | 4.81642918 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.63045960 |
6 | Recurrent viral infections (HP:0004429) | 4.45292008 |
7 | Chronic otitis media (HP:0000389) | 4.37048372 |
8 | Myositis (HP:0100614) | 4.21836455 |
9 | Stomatitis (HP:0010280) | 4.06860375 |
10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.98865782 |
11 | Mediastinal lymphadenopathy (HP:0100721) | 3.98065894 |
12 | Nasal polyposis (HP:0100582) | 3.89807494 |
13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.76230637 |
14 | Recurrent cutaneous fungal infections (HP:0011370) | 3.75388138 |
15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.75388138 |
16 | IgM deficiency (HP:0002850) | 3.72626924 |
17 | Recurrent skin infections (HP:0001581) | 3.72184891 |
18 | T lymphocytopenia (HP:0005403) | 3.61419242 |
19 | Panhypogammaglobulinemia (HP:0003139) | 3.57358058 |
20 | Abnormality of T cell number (HP:0011839) | 3.55278641 |
21 | Obstructive lung disease (HP:0006536) | 3.53435224 |
22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.53435224 |
23 | Abnormality of macrophages (HP:0004311) | 3.52072989 |
24 | Autoimmune thrombocytopenia (HP:0001973) | 3.44637803 |
25 | Pustule (HP:0200039) | 3.43775408 |
26 | Abnormality of the nasal mucosa (HP:0000433) | 3.43148357 |
27 | Meningitis (HP:0001287) | 3.43106830 |
28 | Hypochromic anemia (HP:0001931) | 3.38682687 |
29 | Hypochromic microcytic anemia (HP:0004840) | 3.36496744 |
30 | Inflammation of the large intestine (HP:0002037) | 3.32006543 |
31 | Recurrent bronchitis (HP:0002837) | 3.27818482 |
32 | Abnormality of T cells (HP:0002843) | 3.26804575 |
33 | Orchitis (HP:0100796) | 3.26074821 |
34 | Gastrointestinal inflammation (HP:0004386) | 3.25563709 |
35 | Cellulitis (HP:0100658) | 3.23770100 |
36 | Retrobulbar optic neuritis (HP:0100654) | 3.22651714 |
37 | Optic neuritis (HP:0100653) | 3.22651714 |
38 | Vasculitis (HP:0002633) | 3.21364893 |
39 | Abnormality of the fingertips (HP:0001211) | 3.09451861 |
40 | Colitis (HP:0002583) | 3.00507880 |
41 | Leukocytosis (HP:0001974) | 2.98523407 |
42 | Increased IgE level (HP:0003212) | 2.94765775 |
43 | Gingivitis (HP:0000230) | 2.94713355 |
44 | Spontaneous hematomas (HP:0007420) | 2.92066590 |
45 | Thrombocytosis (HP:0001894) | 2.91776387 |
46 | Abnormality of T cell physiology (HP:0011840) | 2.89759307 |
47 | Eosinophilia (HP:0001880) | 2.83913660 |
48 | Arterial thrombosis (HP:0004420) | 2.82020484 |
49 | Prolonged bleeding time (HP:0003010) | 2.79167890 |
50 | Periodontitis (HP:0000704) | 2.64876809 |
51 | Pulmonary infiltrates (HP:0002113) | 2.63484018 |
52 | Hemoptysis (HP:0002105) | 2.61239216 |
53 | Recurrent sinusitis (HP:0011108) | 2.60162279 |
54 | Increased IgM level (HP:0003496) | 2.60091379 |
55 | Chest pain (HP:0100749) | 2.59633263 |
56 | Episodic fever (HP:0001954) | 2.58462457 |
57 | Abnormality of B cell number (HP:0010975) | 2.57616098 |
58 | B lymphocytopenia (HP:0010976) | 2.57616098 |
59 | Epistaxis (HP:0000421) | 2.57526439 |
60 | Granulocytopenia (HP:0001913) | 2.56676727 |
61 | Petechiae (HP:0000967) | 2.54495041 |
62 | Gingival bleeding (HP:0000225) | 2.54008404 |
63 | Interstitial pulmonary disease (HP:0006530) | 2.52944846 |
64 | Gastrointestinal infarctions (HP:0005244) | 2.45877478 |
65 | Lymphopenia (HP:0001888) | 2.45654157 |
66 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.44863874 |
67 | Microcytic anemia (HP:0001935) | 2.43863343 |
68 | Severe combined immunodeficiency (HP:0004430) | 2.42620270 |
69 | Thyroiditis (HP:0100646) | 2.41654451 |
70 | Abnormality of eosinophils (HP:0001879) | 2.41227021 |
71 | Increased density of long bones (HP:0006392) | 2.40648824 |
72 | Hematochezia (HP:0002573) | 2.40564468 |
73 | Anorexia (HP:0002039) | 2.39638614 |
74 | Osteomyelitis (HP:0002754) | 2.38766611 |
75 | Sepsis (HP:0100806) | 2.36225188 |
76 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.35373004 |
77 | Abnormal platelet function (HP:0011869) | 2.34610590 |
78 | Impaired platelet aggregation (HP:0003540) | 2.34610590 |
79 | Combined immunodeficiency (HP:0005387) | 2.33021663 |
80 | Agammaglobulinemia (HP:0004432) | 2.32256038 |
81 | Abnormality of the pleura (HP:0002103) | 2.30441100 |
82 | Increased cerebral lipofuscin (HP:0011813) | 2.30026848 |
83 | Encephalitis (HP:0002383) | 2.27063767 |
84 | Urticaria (HP:0001025) | 2.24297690 |
85 | Cheilitis (HP:0100825) | 2.22971652 |
86 | Papilledema (HP:0001085) | 2.20744751 |
87 | Vacuolated lymphocytes (HP:0001922) | 2.20321364 |
88 | Viral hepatitis (HP:0006562) | 2.19399117 |
89 | Papilloma (HP:0012740) | 2.19270589 |
90 | Verrucae (HP:0200043) | 2.19270589 |
91 | Chronic sinusitis (HP:0011109) | 2.15513845 |
92 | Chronic diarrhea (HP:0002028) | 2.12658727 |
93 | Keratoconjunctivitis sicca (HP:0001097) | 2.12612877 |
94 | Systemic lupus erythematosus (HP:0002725) | 2.11086229 |
95 | Premature loss of primary teeth (HP:0006323) | 2.10290329 |
96 | IgA deficiency (HP:0002720) | 2.09738711 |
97 | Abnormal platelet volume (HP:0011876) | 2.09318329 |
98 | Joint swelling (HP:0001386) | 2.09238930 |
99 | Hypergammaglobulinemia (HP:0010702) | 2.08476813 |
100 | Skin ulcer (HP:0200042) | 2.07768991 |
101 | Recurrent pneumonia (HP:0006532) | 2.06296574 |
102 | Fatigue (HP:0012378) | 2.04343886 |
103 | Gangrene (HP:0100758) | 2.04139335 |
104 | IgG deficiency (HP:0004315) | 2.03358085 |
105 | Recurrent lower respiratory tract infections (HP:0002783) | 2.03329075 |
106 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02655160 |
107 | Skin rash (HP:0000988) | 2.01661752 |
108 | Keratoconjunctivitis (HP:0001096) | 2.01153212 |
109 | Emphysema (HP:0002097) | 1.98648122 |
110 | Lymphoma (HP:0002665) | 1.92477455 |
111 | Myocardial infarction (HP:0001658) | 1.92293938 |
112 | Pulmonary embolism (HP:0002204) | 1.91790306 |
113 | Slow saccadic eye movements (HP:0000514) | 1.91742160 |
114 | Amyloidosis (HP:0011034) | 1.91496212 |
115 | Glomerulopathy (HP:0100820) | 1.91488112 |
116 | Autoimmune hemolytic anemia (HP:0001890) | 1.91050806 |
117 | Arthralgia (HP:0002829) | 1.89753056 |
118 | Restrictive lung disease (HP:0002091) | 1.89569711 |
119 | Abnormality of the endocardium (HP:0004306) | 1.88976526 |
120 | Increased serum ferritin (HP:0003281) | 1.88817845 |
121 | Thoracic kyphosis (HP:0002942) | 1.88451490 |
122 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.88135628 |
123 | Gastrointestinal stroma tumor (HP:0100723) | 1.87479053 |
124 | Acute myeloid leukemia (HP:0004808) | 1.87447138 |
125 | Purpura (HP:0000979) | 1.86486007 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.00750193 |
2 | TXK | 3.00445631 |
3 | PRPF4B | 2.99591411 |
4 | TYK2 | 2.91704825 |
5 | JAK3 | 2.81894760 |
6 | MAP3K14 | 2.74898872 |
7 | EEF2K | 2.60672919 |
8 | ZAP70 | 2.45582726 |
9 | IRAK4 | 2.44921924 |
10 | BLK | 2.28046894 |
11 | TBK1 | 2.25916266 |
12 | IKBKE | 2.22684001 |
13 | STK10 | 2.07359536 |
14 | MAP3K10 | 2.03690402 |
15 | RIPK4 | 1.98644646 |
16 | IRAK3 | 1.92881892 |
17 | PKN2 | 1.84655618 |
18 | KIT | 1.84487325 |
19 | BTK | 1.81491826 |
20 | JAK1 | 1.81178436 |
21 | GRK6 | 1.78810884 |
22 | TRIB3 | 1.77284530 |
23 | EPHB1 | 1.76267316 |
24 | ITK | 1.76157471 |
25 | FES | 1.71623703 |
26 | MAP3K13 | 1.71075433 |
27 | IKBKB | 1.66171039 |
28 | CSF1R | 1.65765837 |
29 | SIK2 | 1.62179823 |
30 | SYK | 1.58927553 |
31 | HCK | 1.57553681 |
32 | CSK | 1.55907399 |
33 | LCK | 1.47050666 |
34 | TEC | 1.43958373 |
35 | ERN1 | 1.42106216 |
36 | MAP2K3 | 1.40897661 |
37 | FGFR4 | 1.40813981 |
38 | TGFBR2 | 1.38273112 |
39 | TAOK3 | 1.36189701 |
40 | CDK12 | 1.29715404 |
41 | CHUK | 1.20858051 |
42 | RPS6KA4 | 1.20177284 |
43 | PIM1 | 1.16267958 |
44 | CLK1 | 1.13129026 |
45 | FGFR3 | 1.13039154 |
46 | LRRK2 | 1.11942842 |
47 | JAK2 | 1.09656294 |
48 | PTK6 | 1.07944626 |
49 | MAP3K1 | 1.06479432 |
50 | MARK3 | 1.00936715 |
51 | SMG1 | 1.00148465 |
52 | PRKD2 | 0.95757884 |
53 | LYN | 0.91752923 |
54 | TTN | 0.86795170 |
55 | FLT3 | 0.85290564 |
56 | MAPK12 | 0.84320260 |
57 | KSR2 | 0.82951928 |
58 | NEK2 | 0.82620105 |
59 | CDC42BPA | 0.82019152 |
60 | ALK | 0.81408690 |
61 | BMPR2 | 0.81146961 |
62 | TAOK1 | 0.80024593 |
63 | CDK4 | 0.77877946 |
64 | YES1 | 0.77437762 |
65 | MAP3K7 | 0.74581004 |
66 | MAPK7 | 0.71878904 |
67 | NME2 | 0.69938195 |
68 | PDPK1 | 0.69411862 |
69 | MAP3K11 | 0.69348694 |
70 | NLK | 0.67558780 |
71 | CDK19 | 0.66799740 |
72 | CAMKK1 | 0.66546012 |
73 | TAOK2 | 0.65805909 |
74 | FGR | 0.62903619 |
75 | TNK2 | 0.62698109 |
76 | TRPM7 | 0.62394463 |
77 | IRAK2 | 0.62321256 |
78 | PRKCQ | 0.61450392 |
79 | MATK | 0.61034038 |
80 | CAMK1D | 0.60182266 |
81 | STK11 | 0.59621708 |
82 | PIM2 | 0.59069549 |
83 | CDK6 | 0.57460928 |
84 | STK4 | 0.57307938 |
85 | PRKCH | 0.56473411 |
86 | CAMK1G | 0.53548501 |
87 | PDK1 | 0.51974707 |
88 | PAK4 | 0.49840657 |
89 | MAP3K8 | 0.49720509 |
90 | PTK2B | 0.49569419 |
91 | MAP2K2 | 0.49234994 |
92 | PASK | 0.47338904 |
93 | RPS6KA6 | 0.47094418 |
94 | MAPKAPK2 | 0.46405678 |
95 | HIPK2 | 0.46043631 |
96 | DAPK2 | 0.45904998 |
97 | SGK3 | 0.45203961 |
98 | MAP3K3 | 0.44983394 |
99 | MAPK4 | 0.44563588 |
100 | SCYL2 | 0.43919067 |
101 | EPHA3 | 0.43567481 |
102 | EGFR | 0.43031466 |
103 | MAP2K6 | 0.40340418 |
104 | PDGFRB | 0.40086361 |
105 | MST4 | 0.40066370 |
106 | MAP3K6 | 0.40053691 |
107 | DYRK1B | 0.38386808 |
108 | TESK2 | 0.38265460 |
109 | RET | 0.37849586 |
110 | ABL1 | 0.36979395 |
111 | RPS6KC1 | 0.35472389 |
112 | RPS6KL1 | 0.35472389 |
113 | SIK3 | 0.34252451 |
114 | SGK2 | 0.33794896 |
115 | CAMKK2 | 0.33364044 |
116 | BRD4 | 0.32507904 |
117 | PIK3CG | 0.32090573 |
118 | BMX | 0.31943104 |
119 | MAPK11 | 0.29617590 |
120 | CDK9 | 0.28714821 |
121 | TSSK6 | 0.28471601 |
122 | PRKCZ | 0.28281541 |
123 | RPS6KB2 | 0.27915631 |
124 | RPS6KA1 | 0.26348591 |
125 | RPS6KA2 | 0.25041581 |
126 | SIK1 | 0.24615294 |
127 | MARK2 | 0.24384168 |
128 | ATR | 0.24326784 |
129 | FYN | 0.24039555 |
130 | IRAK1 | 0.22748173 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.00556750 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.98715911 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.64964200 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.61972047 |
5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.48104428 |
6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.42826272 |
7 | Measles_Homo sapiens_hsa05162 | 2.38411760 |
8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.24417172 |
9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.09763409 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.03637394 |
11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.98880588 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.96845553 |
13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.92120527 |
14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.89477132 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.84165411 |
16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.84125499 |
17 | Allograft rejection_Homo sapiens_hsa05330 | 1.82706857 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81133142 |
19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.79451794 |
20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.74072779 |
21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.72980085 |
22 | Legionellosis_Homo sapiens_hsa05134 | 1.69116754 |
23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.66234906 |
24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.63694381 |
25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.63525589 |
26 | Influenza A_Homo sapiens_hsa05164 | 1.62016065 |
27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58990368 |
28 | Tuberculosis_Homo sapiens_hsa05152 | 1.58983107 |
29 | Pertussis_Homo sapiens_hsa05133 | 1.53178816 |
30 | Asthma_Homo sapiens_hsa05310 | 1.52073360 |
31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49929715 |
32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49398354 |
33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.46041318 |
34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.45132275 |
35 | Apoptosis_Homo sapiens_hsa04210 | 1.43110634 |
36 | Hepatitis B_Homo sapiens_hsa05161 | 1.40793688 |
37 | Shigellosis_Homo sapiens_hsa05131 | 1.40236239 |
38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32749932 |
39 | Malaria_Homo sapiens_hsa05144 | 1.31079806 |
40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19467982 |
41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15552825 |
42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12997328 |
43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12973602 |
44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08808982 |
45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03781409 |
46 | Salmonella infection_Homo sapiens_hsa05132 | 1.03236512 |
47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02727853 |
48 | Platelet activation_Homo sapiens_hsa04611 | 1.02446096 |
49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01745486 |
50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00923921 |
51 | Hepatitis C_Homo sapiens_hsa05160 | 1.00406750 |
52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96835218 |
53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94441035 |
54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94096901 |
55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93492980 |
56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90776976 |
57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88877491 |
58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88096888 |
59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87654190 |
60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86519570 |
61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85252193 |
62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79627348 |
63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79376572 |
64 | Lysosome_Homo sapiens_hsa04142 | 0.76582463 |
65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71945995 |
66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69250360 |
67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68526702 |
68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68459719 |
69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67664204 |
70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66562130 |
71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64596468 |
72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63890488 |
73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62111507 |
74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61923934 |
75 | Insulin resistance_Homo sapiens_hsa04931 | 0.61662699 |
76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60590740 |
77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59855252 |
78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59127402 |
79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57380947 |
80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55174052 |
81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54132263 |
82 | DNA replication_Homo sapiens_hsa03030 | 0.53805565 |
83 | Phagosome_Homo sapiens_hsa04145 | 0.50364187 |
84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49594853 |
85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47172670 |
86 | Endocytosis_Homo sapiens_hsa04144 | 0.46118509 |
87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46072118 |
88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45797189 |
89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45522895 |
90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.45502509 |
91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45318526 |
92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44973559 |
93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44477517 |
94 | Amoebiasis_Homo sapiens_hsa05146 | 0.44462426 |
95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42318609 |
96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42004388 |
97 | Base excision repair_Homo sapiens_hsa03410 | 0.41584533 |
98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41450654 |
99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40267397 |
100 | Prostate cancer_Homo sapiens_hsa05215 | 0.38569759 |
101 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36730304 |
102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34435479 |
103 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34265280 |
104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33348339 |
105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32112266 |
106 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.30903778 |
107 | ABC transporters_Homo sapiens_hsa02010 | 0.30424476 |
108 | Lysine degradation_Homo sapiens_hsa00310 | 0.30231188 |
109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29989572 |
110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29092993 |
111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28528684 |
112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28428779 |
113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28050599 |
114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27039098 |
115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26886950 |
116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.25935949 |
117 | Glioma_Homo sapiens_hsa05214 | 0.25161427 |